P. Mondejar (El Palmar Murcia, Spain)
The childhood evaluation of salmeterol tachyphylaxis study (CHEST) W. D. Carroll, P. Boit, I. Cliff, P. W. Jones, W. Lenney (Stoke-on-Trent, Keele, United Kingdom)
| |
Does a short course of oral glucocorticoids interfere with immune response in children with acute asthma? F. M. Ducharme, S. Resendes, X. Zhang, H. D. Ochs, M. Bruce (Montreal, Canada; Seattle, United States Of America)
| |
Effect of fluticasone and montelukast in preschool children with asthma-like symptoms E. M. W. Kooi, S. Schokker, H. M. Boezen, T. W. de Vries, A. A. P. H. Vaessen-Verberne, T. van der Molen, E. J. Duiverman (Groningen, Leeuwarden, Breda, Netherlands)
| |
Adult height in children treated with inhaled budesonide is normal but reached late L. Agertoft, S. Pedersen (Kolding, Denmark)
| |
Suboptimal persistence with inhaled corticosteroid (ICS) mono-therapy among children with persistent asthma in the UK Q. Zhang, S. D. Taylor, V. Sazonov-Kocevar, M. Thomas, D. Price (Whitehouse Station, United States Of America; Aberdeen, United Kingdom)
| |
Lack of tolerance to the bronchoprotective effect with intermittent administration of salmeterol M. Miraglia del Giudice, L. Pietroni, F. Decimo, F. M. de Benedictis (Naples, Ancona, Italy)
| |
Association between tuberculin skin test and serum IgE level in asthmatic children N. Baghaie, M. R. Masjedi, S. Khalilzadeh, S. S. Hakimi (Tehran, Islamic Republic Of Iran)
| |
Evaluation of relationship between total serum IgE level with BCG scar diameter in asthmatic children E. Razi, P. Amiri, G. Mossavi (Kashan, Islamic Republic Of Iran)
| |
The use of pressurized metered-dose inhalers mith spacer in the treatment of asthmatic crises: impacts on treatment costs J. P. B. Lotufo, H. M. Sabino, R. C. Calheiros, F. Stollar, D. M. Cardoso (São Paulo, Brazil)
| |
Use of spacers in pediatric ER J. P. B. Lotufo, H. M. Sabino, J. M. G. Mendes, B. M. Machado, M. Paulis (São Paulo, Brazil)
| |
Antibody response after varicella vaccination similar in children treated with budesonide inhalation suspension (BIS) or nonsteroidal conventional asthma therapy (NSCAT) K. Murphy, K. Ververeli, B. M. Harvey, A. L. Duke, J. Chapas-Crilly, T. Uryniak, E. Lyzell, W. Mezzanotte (Omaha, Collegeville, Jonesboro, Little Rock, Wilmington, United States Of America)
| |
Comparison of ciclesonide 160 μg/d with budesonide 400 μg/d in a randomised, double-blind study in children with moderate to severe asthma A. von Berg, J. H. Vermeulen, W. Zachgo, S. Hellbardt, T. D. Bethke, R. Engelstätter (Wesel, Geesthacht, Konstanz, Germany; Cape Town, South Africa)
| |
Comparison of once-daily ciclesonide 160 μg versus twice-daily fluticasone propionate 88 μg in children with moderate to severe asthma L. Hiremath, T. Mohan-Kumar, V. Singh, P. Raman, U. Ramsperger, R. Engelstätter (Pune, Coimbatore, Jaipur, India; Konstanz, Germany)
| |
Long-term treatment with ciclesonide once daily has no effect on growth velocity, skeletal maturity and HPA-axis function in children with mild persistent asthma D. Skoner, C. E. Baena-Cagnani, J. Maspero (Pittsburgh, United States Of America; Cordoba, Buenos Aires, Argentina)
| |
Relationship between number of tidal breaths and drug delivery via spacer in pre-school children A. Schultz, P. N. Le Souef, R. Thomas, S. Devadason (Perth, Australia)
| |
Formoterol-HFA pMDI is effective and well tolerated in children with persistent asthma F. Bonnet-Gonod, M. Ballabio, L. Barkai, G. Dobra, I. Kottakis (Courbevoie, France; Parma, Italy; Miskolc, Mosonmagyarovar, Hungary)
| |
Active oxigen species generation by leukocytes in infants with bronchial asthma N. A. Sazhina, N. A. Geppe, S. B. Bolevich (Moscow, Russian Federation)
| |
Safety of inhaled corticosteroids reduction in asthmatic children E. Paraskakis, E. Dilanas, A. Moissiadi, M. Kalmanti (Heraklion, Greece)
| |
In vitro performance of a small non-electrostatic valved holding chamber made from metal with three different brands of pressurized metered dose inhalers K. Perkes, S. Neckermann, N. Tiffin (Salt Lake City, Midlothian, United States Of America; Starnberg, Germany)
| |
A submicron suspension of budesonide improves the mass of ICS delivered during early nebulization A. P. Bosco, T. A. Armer, P. S. Uster (Mountain View, United States Of America)
| |